Share-Based Awards (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

Assumptions used to calculate the grant date fair value of the performance shares with a relative TSR market condition and the aspirational performance shares, by grant date, were as follows:

Performance Share Grants:

	February 2023		February 2022		May 2021		February 2021
Expected volatility	53.9	%	55.0	%	55.0	%	52.0	%
Risk-free interest rate	4.08	%	1.58	%	0.27	%	0.18	%

Aspirational Share Grants:

	August 2022
Expected volatility	54.5	%
Risk-free interest rate	3.23	%

Schedule of Restricted Stock Units and Performance Shares Settled in Stock Transactions

The activity for these awards for the year ended December 31, 2023 was as follows (in thousands, except for per share amounts):

	Shares & Units	Weighted-Average Fair Value Per Share
Nonvested, beginning of period	4,560	$	27
Granted	723	$	46
Vested	(818)	$	38
Forfeited	(361)	$	32
Nonvested, end of period	4,104	$	28

Schedule of Restricted Stock Units and Performance Shares Settled in Cash Transactions

The activity for these awards for the year ended December 31, 2023 was as follows (in thousands, except for per share amounts):

	Units	Weighted-Average Fair Value Per Share
Nonvested, beginning of period	245	$	38
Granted	105	$	48
Vested	(112)	$	40
Forfeited	(21)	$	36
Nonvested, end of period	217	$	36

Schedule of Stock Option Transactions

The stock option transactions for the year ended December 31, 2023 were as follows (in thousands, except for per share amounts):

	Options	Weighted-Average Exercise Price
Outstanding, beginning of period	913	$	47
Options granted	—	$	—
Exercised	—	$	—
Forfeited	(287)	$	59
Outstanding, end of period	626	$	42
Exercisable, end of period	251	$	50

Schedule of Aggregate Intrinsic Value Related to Options Outstanding, Exercisable and Exercised

The aggregate intrinsic value related to stock options exercised, outstanding and exercisable as of and for the years ended December 31, was as follows (in thousands):

	2023		2022		2021
Exercised	$	—	$	—	$	289
Outstanding	$	105	$	2,485	$	530
Exercisable	$	—	$	—	$	—

Schedule Stock Options Outstanding by Price Range

Stock options outstanding at December 31, 2023 were as follows (options in thousands):

Price Range	Weighted-Average Contractual Life	Options	Weighted-Average Exercise Price
$30.01 to $40	7.9	500	$	37
$40.01 to $50	0.0	—	$	—
$50.01 to $60	0.0	—	$	—
$60.01 to $70	0.4	126	$	63
Options outstanding	6.4	626	$	42
Options exercisable	4.1	251	$	50